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Recently, we characterized a monoclonal murine helper T cell (TH) 1 line, Vir- 
2,  which  responds  to  the  hemagglutinin (HA)  of  PR8  influenza  virus  and 
syngeneic antigen-presenting cells (APC) by specific proliferation, secretion of 
factors, and by delivering help for antibody production in vitro, or in nude mice 
after transfer and challenge by influenza infection (1). Vir-2 recognition of HA 
was approached by assaying proliferation on a  panel of mutant viruses having 
known amino acid substitutions in the HA1 polypeptide. One of these mutants, 
which  had  a  substitution of Glu--~Lys  at  position  115  of the  HA1,  was  not 
recognized by Vir-2. 
This alteration could conceivably abrogate the stimulatory capacity of the HA 
molecule at different levels:  for example, through long-range conformational 
effects  or  by  conferring  different  susceptibility  of the  molecule  to  antigen 
processing, as well as by altering the specific residues contacted by the T  cell 
receptor or by H-2 I region products (2-5). To further characterize the stimu- 
latory determinant, biochemical localization of the recognized site was under- 
taken using purified HA and synthetic peptide homologues. 
This paper identifies the site in HA recognized by Vir-2 cells. By identification 
of active cleavage fragments of HA, followed by synthesis of short peptides of 
the active segment, HA recognition by Vir-2 was delimited to a sequence of nine 
amino acids (positions 111-119)  containing G]UllS, which had mutated in the 
nonstimulatory variant.  This sequence, which is  located in the globular head 
region of the  HA,  is  conserved in the currently sequenced human influenza 
viruses of the H1 subtype from 1934-1957 and 1977-1980, which explains the 
broad recognition of those viruses by Vir-2 cells. 
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Materials and Methods 
Vir-2 Cell Line and Proliferation Assays.  The HA-specific Tu cell line Vir-2 was selected 
from the spleen of a  BALB/c mouse immunized intraperitoneally with PR8 influenza 
virus, and cultured as previously described (1). 
Proliferation assays were done in flat-bottomed microtiter wells (Linbro; Flow Labora- 
tories, Inc., Hamden, CT) in a  0.2-ml final volume containing 1 ×  104-2  ×  104 Vir-2 
cells, 4 ×  10  s irradiated spleen cells, and dilutions of antigen. At 48 h of culture, 0.2-0.5 
#Ci of [SH]thymidine (New England Nuclear, Boston, MA) (1 Ci = 3.7 ×  10 l° becquerels) 
was added in a 25-#1 volume, and cells were harvested 12-16 h later onto glass fiber disks 
(Flow Laboratories, Rockville,  MD) for liquid scintillation counting. 
Viruses  and  HA  Purification.  Type  A  influenza  virus  PR8  (A/Puerto  Rico/8/ 
34,H 1N 1), originally obtained from Mt. Sinai Hospital, New York, was grown in embryon- 
ated chicken eggs and titered by hemagglutination (6). Virus in allantoic fluid was used 
in proliferation assays without further purification. 
The glycoproteins HA and neuraminidase (NA) were solubilized from purified virus 
by bromelain digestion according to Brand and Skebel (7)  using a  1:10  enzyme/viral 
protein ratio. NA was removed from the sucrose density gradient-purified glycoprotein 
peak  by the  monoclonal anti-NA  antibody H17/L17  (8)  immobilized on  protein  A- 
Sepharose (Pharmacia Fine Chemicals, Piscataway,  NJ) according to Gersten and Mar- 
chalonis (9). HA purity was assessed by sodium dodecyl sulfate (NaDoSO4) polyacrylamide 
gels (by the presence of only a single band in unreduced gels) and by radioimmunoassay 
(by the lack of binding to the preparation of a mixture of monoclonal antibodies specific 
for each of the NA, matrix protein, or nucleoprotein components of influenza). 
HA Polypeptide Separation  and Cleavage Products.  Purified HA was separated into the 
heavy  HA1  chain  and  the  bromelain-shortened  HA2  polypeptide  by  reduction  and 
alkylation according to Skehel and Waterfield (10). Chains were isolated by chromatog- 
raphy on Sephacryl S-200 (Pharmacia Fine Chemicals) in 6 M urea, 0.2 M propionic acid. 
The HA 1 chain was cleaved at methionine residues by cyanogen bromide (CNBr)  as 
recently described (11). Cleavage by CNBr at tryptophan residues was done according to 
Huang et ai. (12). Fragments of HA1 were separated by high-pressure liquid chromatog- 
raphy (HPLC) size exclusion chromatography on an 1-125 column (Waters Associates, 
Millipore Corp., Milford, MA), as described by Waterfield et al. (11). 
Peptide Synthesis.  Peptides were synthesized using the solid-phase  method developed 
by Merrifield (13) or normal liquid-phase synthesis. To verify homogeneity and composi- 
tion of active peptides, 100 mg of product was purified by HPLC using a preparative C 18 
ODS  column (Waters Associates).  Elution conditions were as  follows:  buffer A, 0.1% 
CFsCOOH in H20; buffer B, 0.1% CF3COOH in H20/CHsCN,  30:70.  The gradient 
was 25-90%  buffer B for 50 rain with a  flow rate of 7 ml/min. After purification, 20 
nmol of the peptide was subjected to automated Edman degradation as recently described 
(14), and shown to contain the complete expected sequence. 
Results 
Vir-2 Recognition of Purified HA and Cleavage Products.  Table I shows that Vir- 
2 cells proliferate in response to the HA of PR8 virus, provided as whole virus 
or as purified HA, in the presence of H-2 a APC. Further, the stimulatory activity 
of the HA molecule was associated with the HA1  polypeptide chain. The small 
degree of stimulation observed with a relatively large amount of HA2 probably 
resulted from a  slight contamination of the HA2  preparation  with HA1.  The 
isolated HA1  chain  was  efficiently recognized  after reduction  and  alkylation, 
which  suggests  that  the  native  HA  conformation  is  not  required  for  Vir-2 
recognition. 
This stimulatory activity was maintained after cleavage of the HA 1 at Met or 
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TABLE  I 
Region of the HA Recognized by Vir-2 Cells Resides Entirely in the HA1 Chain 
Antigen  Form  Concentration 
Uptake of [SH]thymi- 
dine (cpm) by Vir-2 
on APC of strains* 
BALB/c  C3H/HeJ 
(H-d  °  )  (H-2  k) 
None  --  144  159 
PR8 virus  Allantoic fluid  6 HAU/ml  13,584  119 
HA  Bromelain-solubilized trimers  135 ng/ml  13,479  164 
HA 1 chain  Reduced and alkylated  80 ng/ml  13,341  134 
8 ng/ml  3,867  95 
0.8 ng/ml  297  120 
HA2 chain  Reduced and alkylated  200 ng/ml  1,191  224 
20 ng/ml  169  192 
HA1-CNBr-1  Cleaved at Met residues  300 ng/ml  8,284  96 
30 ng/ml  12,316  113 
HA1-CNBr-2  Cleaved at Met and Trp resi-  1,000 ng/ml  8,462  160 
dues  100 ng/ml  8,082  115 
10 ng/ml  590  179 
* Data  are  mean  counts per  minute  of four to  six wells in  replicate.  Proliferation assayed  as in 
Materials and Methods. 
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FIGURE  1.  HPLC  separation  of fragments  of PR8  HA1  after  chemical  cleavage at  Trp 
residues by Vir-2 TH cells. Fragments of reduced and alkylated HA1 from CNBr digestion at 
Trp residues were separated on Waters 1-125  sizing columns. Peaks, identified by A2s0, were 
pooled and tested in proliferation assays using Vir-2 cells. The histograms show stimulation of 
fractions relative to that obtained by the same dilution of unseparated HA1 CNBr digest. 
that was recognized was approached as shown in Fig.  1. After CNBr cleavage at 
only Trp  residues,  the  mixture of HA1  fragments was chromatographed on 
HPLC  sizing columns.  Pools  of partially resolved peaks were tested for their 
ability to  stimulate Vir-2  cells in  a  proliferation assay.  Maximum activity was 
found in peak B (histogram, Fig. 1). N-terminal sequencing was then performed 
in order to define the peptide present in peak B. In each degradation step, two 
distinct residues were identified, which were compared with the known amino 
acid sequence of PR8 HA1 (15). The sequence of peptide B-1 was found to be: 
H2N-  -Leu-Leu-Lys-Pro-Asp-.  This  corresponds  to  residues  232-237  and 
identifies the N-terminus of the C-terminal HA1 fragment (231-325) following 
Trp2so. The N-terminal sequence of 13-2 was:  H2N-  -Tyr-Ile-Val-Glu-, which 
matches residues 78-81 and identifies the peptide fragment 77-123. Considering HACKETT ET  AL.  297 
that the latter  contains position  115,  which had been  implicated in the Vir-2 
recognition process by the previous mutant analysis (1), we decided to synthesize 
the segment around position 115 according to the wild-type sequence. 
Synthetic  Peptides  of the Recognized  Sequence.  A  series  of peptide homologues 
ranging from 5 to 11 amino acids in length were synthesized covering positions 
within  109-120  (Table  II).  Vir-2  cells  proliferated  in  response  to  the  initial 
product, an undecapeptide of the region 109-119. Shorter peptides synthesized 
from either  the  C-terminal  LySll9 or  Glul~0 were  recognized by  the Tia  only 
when extended in the amino terminal direction to include Pbell~. By this analysis, 
recognition of HA by Vir-2 was delimited to the sequence of nine amino acids 
(Table II). Since the C-termini of the peptides were not extensively varied, the 
possibility remains that a  somewhat shorter peptide may also be recognized by 
Vir-2 (see Discussion). 
No evidence was found for toxicity to the TH or APC as the basis for the lack 
of stimulation  by  the  shorter  peptides;  Vir-2  cells  proliferated  maximally  in 
response to PR8 HA in the presence of each shorter homologue (Table II). 
Some  peptides,  especially  those  covering positions  112-120  and  113-120, 
were not fully soluble in aqueous media, thereby necessitating studies in which 
the panel of peptides was solubilized in various detergents (NaDoSO4,  sodium 
cholate,  octyl glucoside).  These detergents did not appreciably decrease Vir-2 
proliferation in the presence of sufficient bovine serum albumin (0.05-2.5  g/ 
100  ml) (not illustrated).  None of these peptides were mitogenic for Vir-2,  as 
observed by their failure to stimulate in the presence of H-2 k APC. 
Efficiency  of Stimulation:  Whole  HA  vs.  Smaller Products.  Although only pico- 
grams  per  milliliter  of purified  trimers  of  HA  were  required  for  threshold 
stimulation of Vir-2 in our proliferation assay, the synthetic peptides were needed 
in microgram per milliliter quantities.  Table  III shows that,  on a  molar basis, 
intact  HA  is  106-107  times  more  efficient  than  the  peptides,  with  the  HA1 
polypeptide and cleavage products distributed in between. Apparently, the longer 
TABLE  II 
Localization  of Vir-2 HA Recognition  to a Nine Amino Acid Sequence in the HA1 
Synthetic peptide covering the segment 109-120 
in PR8 HA1 
109 110 111  112  113  114  115 116 117  118 119 120 
Stock 
Uptake of [3H]thymidine 
(cpm) by Vir-2 on  Peptide 
BALB/c APC:  ( 10  -3) 
Dilution of peptide  plus pu- 
rified 
10 -2  10  -3  10  -4  HA* 
mg  / ml 
Ser-Ser-Phe-Glu-Arg-Phe-Glu-Ile-Phe-Pro-Lys  80  41,197  13,791  566  ND 
Ile-Phe-Pro-Lys-Glu  1  381  513  617  56,554 
Glu-Ile-Phe-Pro-Lys-Glu  1  741  743  1,229  54,705 
Phe-Glu-  Ile-  Phe- Pro- Lys-Glu  1  412  560  840  57,391 
Arg-  Phe-Glu-  Ile-  Phe- Pro- Lys-Glu  1  226  658  760  56,215 
Glu-  Arg-  Phe-Glu-  Ile-  Phe- Pro-Lys-Glu  1  387  813  668  54,238 
Phe-Glu-Arg-Phe-Glu-Ile-Phe-Pro-Lys  5  54,182  29,868  6,526  ND 
Cys-Phe-Glu-Arg-Phe-Glu-Ile-Phe-Pro-Lys-Glu  1  12,685  40,621  765  69,252 
* Uptake, HA alone is 57,438. 298  HELPER  T  CELL RECOGNITION OF  INFLUENZA HEMAGGLUTININ 
TABLE III 
Comparative Efficiencies of Vir-2 Stimulation by HA and Smaller 
Products, All Containing the Recognized Sequence 
Amino acid  Antigen  length  Relative  molar efficiency* 
Peptide 109-119  11  1 
Peptide 111-119  9  1 
HA (CNBr at Trp)  47  3,500-7,000 
HA (CNBr at Met)  226  120,000 
HA1  325  200,000-400,000 
HA  500  106-107 
* Calculated from the molar concentration of a given antigen sufficient 
for a threshold  level of  Vir-2 stimulation  in a standard  proliferation  assay 
(see Materials and Methods), divided into the molar concentration re- 
quired for similar stimulation by the 11  amino acid synthetic  peptide 
(position 109-119). 
the  segment  embodying the  recognized  sequence,  the  more  efficiently it  is 
recognized. 
Discussion 
The HA site recognized by Vir-2 TH cells was localized to a sequence of nine 
amino acids (positions 111-119)  in the PR8  influenza HA1  chain. Peptides of 
different lengths, synthesized from the C-terminal positions  119  or  120,  were 
not recognized until extended according to the PR8  HA sequence to Phe~. 
Replacement at position  110  with the foreign Cys did not alter recognition of 
the stimulatory peptide. However, it is not known whether Vir-2 cells could also 
recognize peptides shortened further between positions  115  (known to be re- 
quired from the  mutant analysis; see  reference  1)  and  residue  119,  since  C- 
termini were not extensively varied. 
One complication in defining a  recognition site by comparing responses  to 
protein region homologues of different lengths is that these peptides can vary 
greatly in solubility. For example, two of the larger nonstimulatory octa- and 
nonapeptides were poorly soluble in water. Dissolving these peptides with deter- 
gents  did  not  render  them  stimulatory for  Vir-2.  Elongation  at  the  amino 
terminus simultaneously conferred water solubility and the ability to be recog- 
nized by Vir-2. It is not known whether these two properties are causally related, 
but  it  seems  that  inherent  characteristics  of certain  homologues  may  have 
unknown effects upon their functioning in assays. 
The  nonapeptide  111-119  is  the  smallest  sequence  known  thus  far  to  be 
recognized by influenza virus-specifi  c  TH cells.  Lamb et ai.  (16)  identified an 
immunodominant peptide for HA-specific human TH cells covering the carboxy- 
terminal 25  amino acids of the H3 subtype HA1  chain. This peptide is in the 
stem region of the molecule, distant on the three-dimensional structure from the 
major sites in the globular head region where neutralizing antibodies are thought 
to bind in that strain (17).  Smaller subunits of this 25  amino acid peptide, all 
having the  same  C-terminus,  were  found to  be  nonstimulatory for  these  TH 
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Peptides as small as eight or nine amino acids are known to be recognized by 
T  cells in other systems. Thomas et al. (18) have shown that T  cells from guinea 
pigs immunized with the octapeptide angiotensin II specifically recognize that 
antigen in culture.  Guinea pig T  cells raised to insulin B chain are capable of 
responding to a synthetic eight amino acid segment of the antigenic region (4). 
Similarly, the main encephalitogenic determinant in guinea pigs for the T  cell- 
associated disease  experimental  allergic  encephalomyelitis is a  nonapeptide  of 
myelin basic protein (19). Therefore, our peptide ranks in size among the smallest 
known as T  cell antigens. 
Although both the intact HA molecule and active synthetic peptides are capable 
of eliciting maximal Vir-2 proliferation at optimal doses and have the same major 
histocompatibility complex restriction requirements, the stimulation efficiencies 
of these antigens differ greatly. Whereas  "-20 pg/mi (~-100 fM concentration) 
suffices for the HA trimer, the threshold for stimulation with peptides was "~ 1 
#g/ml (1  #M).  This difference of "~ 106 appears mainly to reflect the extreme 
sensitivity of Vir-2 for the native HA, since the concentration thresholds for T 
cell  stimulation  in  other  systems are  closer  to  the  values  we obtain  with  the 
undeca- and nonapeptides (2-4,  20-22).  The basis of this sensitive response is 
not  clear.  Binding of the  HA  timer  to  cell-surface  sialic  acid  may  focus the 
antigen on APC. Other possibilities could be different aggregation states of the 
antigens, or effects of glycosylation upon solubility or uptake. Thomas et al. (4) 
found that although an octapeptide of insulin was recognized by immune guinea 
pig T  cells, it was less efficient in stimulating T  cells than slightly larger (11 or 
13 amino acid) overlapping peptides. The authors suggested that a conformation 
favorable  for  maximum  T  cell  stimulation  might be  stabilized  by  the  larger 
peptides. The possibility that additional nonspecific residues extraneous to the 
T  cell  recognition site  may increase stimulatory efficiency is under study and 
could provide insight into the mechanism of antigen handling by APC. 
The location of peptide  111-119 on the three-dimensional model of the H3 
subtype HA (23) places it in the globular head region, where it would be on the 
exposed surface of the HA trimer. By laboratory selection of virus mutants with 
15  mouse monoclonal anti-HA  antibodies,  only a  single mutant was  obtained 
with a  residue change in that region, whereas numerous mutants were selected 
that possessed residue changes in HA1  segments that flank this peptide in the 
three-dimensional structure  (15).  This suggests that residues  111-119  do not 
constitute an  important  determinant  for  murine antibodies.  In  contrast,  this 
segment seems to be the target of a commonly occurring murine T  cell reactivity 
since TR clones generated from two additional BALB/c mice have recently been 
found  that  recognize  the  109-119  sequence  of  PR8  HA1  (J.  L.  Hurwitz, 
manuscript in preparation). These observations are similar to those reported for 
glucagon (24), lysozyme (20), angiotensin II (18), and myoglobin (21, 22), which 
indicates that  B  and  T  cells commonly focus onto different determinants on 
protein antigens. 
This characteristic may explain our observation that the determinant identified 
by Vir-2 reactivity is present in all of the subtype H 1 influenza viruses that have 
been tested so far (more than  15 strains, isolated originally within years  1934- 
1957 and  1977-1980)  (1).  No anti-HA antibodies exhibit such cross-reactivity, 300  HELPER  T  CELL RECOGNITION OF  INFLUENZA HEMAGGLUTININ 
which reflects the antigenic drift that presumably results from accumulation of 
point mutations in regions of the HA recognized by virus-neutralizing antibodies 
in the human population. Thus, as in BALB/c mice, the segment recognized by 
Vir-2 does not appear to be an important target structure for human neutralizing 
antibodies. This raises the question of whether, in an analogous way, the region 
is a  significant determinant for human Tn.  It should be noted in this context 
that Lamb et al. (16) obtained good levels of proliferation by human peripheral 
blood lymphocytes in response to a  synthetic peptide covering positions  105- 
140 of the subtype H3 HA molecule. We are currently studying recognition of 
the H 1 HA by donor human T  lymphocytes. 
Summary 
The functional helper T  cell line Vir-2, derived from a PR8 (H1N1) influenza 
virus-immunized BALB/c mouse, proliferates in response to syngeneic antigen- 
presenting cells and naturally occurring strains of subtype H 1 human influenza 
virus  from  1934-1957  and  1977-1980  isolates.  A  conserved  region  of the 
hemagglutinin  molecule around amino acid  position  115  in  the  heavy chain 
(HA1)  was  implicated  as  being  important  in  this  recognition by  the  lack  of 
stimulatory  activity  associated  with  a  glutamic  acid  to  lysine  substitution  at 
position 115 in the laboratory mutant RV6, derived from wild-type PR8. Char- 
acterization  of the  stimulatory  determinant  on  the  wild-type  hemagglutinin 
molecule was then undertaken using cleavage products and synthetic peptides. 
Vir-2 cells recognized the reduced and alkylated purified HA1 of PR8 virus, and 
this reactivity was retained after cleavage at methionine and tryptophan residues. 
High-pressure liquid chromatography separation of cleavage fragments indicated 
that a short sequence of the HA1 containing residue 115 was being recognized. 
This recognition was localized to a nine amino acid segment (positions 111-119) 
by assaying stimulation with synthetic peptide homologues of different lengths 
from that region. As with native hemagglutinin, Vir-2 cells responded to active 
peptides when presented by H-2  a but not H-2  k antigen-presenting cells. 
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